Milestone Pharmaceuticals Inc. (MIST) Tops Q2 EPS by 5c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• UBS Starts Compass Gas e Energia SA (PASS3:BZ) at Buy
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities